Esegui ricerca
Sorina Buzatu, France, Medicine
Nicolas Mouz - progressing towards an efficient HIV vaccine
Nicolas Mouz - progressing towards an efficient HIV vaccine
European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .
A HIV vaccine preventing healthy cells’ infection
A HIV vaccine preventing healthy cells’ infection
AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41 , is based on one of the envelope proteins of the HIV virus , called the gp41 protein.